Filing Details

Accession Number:
0001140361-16-047340
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-01-08 19:27:27
Reporting Period:
2016-01-06
Filing Date:
2016-01-08
Accepted Time:
2016-01-08 19:27:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1302573 Oncomed Pharmaceuticals Inc OMED Pharmaceutical Preparations (2834) 383572512
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1553335 Jakob Dupont C/O Oncomed Pharmaceuticals, Inc.
800 Chesapeake Drive
Redwood City CA 94063
Svp & Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-01-06 2,092 $22.30 20,712 No 4 S Direct
Common Stock Disposition 2016-01-06 69 $21.54 20,643 No 4 S Direct
Common Stock Disposition 2016-01-07 1 $21.33 20,642 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Pursuant to a sell-to-cover election made by the Reporting Person at the time of the initial grant of the restricted stock unit award, the shares were sold upon the vesting of restricted stock units solely to cover applicable withholding taxes.
  2. Includes 15,000 restricted stock units. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) restricted stock unit.